Search results for "papi"

showing 10 items of 636 documents

Impact of a new carrageenan-based vaginal microbicide in a female population with genital HPV-infection: First experimental results

2019

OBJECTIVE: The objective of this study was to assess safety, satisfaction, and anti- viral effect of a new carrageenan-based vaginal microbicide in a population of fertile female patients with genital human papillomavirus (HPV) infection. PATIENTS AND METHODS: Forty healthy and sexually active women aged 18-45 years with genital HPV infection were enrolled. Each subject was treated with a gel formulated with 0.02% carrageenan and Propionibacterium extract (CGP) (Carvir, Depofarma SpA, Mogliano Veneto, Treviso, Italy). The subjects were evaluated at baseline, after the I cycle of therapy and after the II cycle. At final status, treatment acceptability and satisfaction were evaluated using a …

AdultSettore MED/07 - Microbiologia E Microbiologia ClinicaHPVAdolescentSocio-culturaleMicrobicideCarrageenanCarrageenan Papillomavirus Microbicide Female population HPV.Young AdultAnti-Infective AgentsChondrusHumansProspective StudiesCarrageenan Papillomavirus Microbicide Female population HPVPapillomaviridaeFemale populationPapillomavirus InfectionsMiddle AgedPapillomavirusSeaweedAdministration IntravaginalTreatment OutcomeColposcopyPatient SatisfactionCase-Control StudiesDNA ViralVaginaVaginal Creams Foams and JelliesFemaleFollow-Up Studies
researchProduct

Immunohistochemical expression of ubiquitin and telomerase in cervical cancer

2009

Artículo publicado en: Virchows Arch (2009) 455:235–243. DOI 10.1007/s00428-009-0818-7 Ubiquitin and telomerase immunohistochemical expression patterns in cervical cancer were compared with normal cervical tissue samples. Eighty-one cervical cancer cases and 22 normal exo–endocervical tissue were examined with polyclonal antibody for ubiquitin and 44G12 clone for telomerase using tissue microarrays. The results were interpreted using a semiquantitative scale The average age of patients was 50.67 years. The most frequent histological types were moderately differentiated epidermoid carcinoma (43.5%), according to the degree of differentiation, and endocervical adenocarcinoma (42.1%). Immunohi…

AdultTelomerasePathologymedicine.medical_specialtyBiologíaClone (cell biology)Uterine Cervical NeoplasmsCervix UteriBiologyPathology and Forensic MedicineUbiquitinBiomarkers TumormedicineHumansPapillomaviridaeTelomeraseMolecular BiologyAgedCervical cancerTissue microarrayUbiquitinCancerArtículosCell BiologyGeneral MedicineMiddle AgedFacultad de Farmacia y Bioanálisismedicine.diseaseImmunohistochemistryImmunohistochemical expressionEpidermoid carcinomaTissue Array AnalysisCervical cancerbiology.proteinImmunohistochemistryFemaleVirchows Archiv
researchProduct

Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 y…

2009

This observer-blind study compared the prophylactic human papillomavirus (HPV) vaccines, Cervarix (GlaxoSmithKline) and Gardasil (Merck), by assessing immunogenicity and safety through one month after completion of the three-dose vaccination course. Women (n = 1106) were stratified by age (18-26, 27-35, 36-45 years) and randomized (1:1) to receive Cervarix (Months 0, 1, 6) or Gardasil (Months 0, 2, 6). At Month 7 after first vaccination, all women in the according-to-protocol cohort who were seronegative/DNA negative before vaccination for the HPV type analyzed had seroconverted for HPV-16 and HPV-18 serum neutralizing antibodies, as measured by pseudovirion-based neutralization assay (PBNA…

Adultmedicine.medical_specialtyAdolescentImmunologyAntibodies ViralCancer VaccinesSerologyYoung AdultHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Neutralization TestsInternal medicinemedicineHumansPapillomavirus VaccinesGeneral Pharmacology Toxicology and PharmaceuticsNeutralizing antibodyPapillomaviridaeCervical cancerbiologybusiness.industryImmunogenicityGardasilPapillomavirus InfectionsMiddle Agedmedicine.diseaseAntibodies NeutralizingVaccinationImmunologyCohortbiology.proteinFemaleCervarixbusinessmedicine.drugHuman Vaccines
researchProduct

Double Endocrine Neoplasia in a Renal Transplant Recipient: Case Report and Review of the Literature

2011

Abstract Introduction The incidence of cancer compared for age groups is 3–4 times higher in transplant recipients than the general population. The increased risk is related to immunosuppressive therapy as well as the use of increasingly older donors and recipients. Although cardiovascular disease with a functioning transplant is the leading cause of death (47%), cancer mortality is significant especially among older patients. However, the most frequent posttransplantation cancers relate to hemolymphopoietic organs and skin, whereas the occurrence of solid tumors elsewhere is rare. Herein we have described a rare case of synchronous double malignancy of endocrine organs (thyroid-adrenal) in…

Adultmedicine.medical_specialtyBiopsymedicine.medical_treatmentAdrenal neoplasmSettore MED/08 - Anatomia PatologicaNephrectomyEndocrine neoplasia renal transplant recipientAdrenocortical CarcinomamedicineAdjuvant therapyHumansAdrenocortical carcinomaThyroid NeoplasmsMultiple endocrine neoplasiaThyroid cancerNeoplasm StagingTransplantationOxyphil Cellsbusiness.industryCarcinomaGraft SurvivalMultiple Endocrine NeoplasiaThyroidectomyAdrenalectomyMycophenolic Acidmedicine.diseaseKidney TransplantationAdrenal Cortex NeoplasmsCarcinoma PapillaryNephrectomySurgeryTransplantationSettore MED/18 - Chirurgia GeneraleTreatment OutcomeThyroid Cancer PapillaryCyclosporineThyroidectomyKidney Failure ChronicLymph Node ExcisionDrug Therapy CombinationFemaleSteroidsSurgeryTomography X-Ray ComputedbusinessImmunosuppressive AgentsTransplantation Proceedings
researchProduct

Prevalence of human papillomavirus types in women screened by cytology in Germany.

2007

Incidence and mortality rates of cervical cancer are higher in Germany than in other Western European countries. Type-specific human papillomavirus (HPV) distribution was investigated for the first time in Germany in an epidemiological study including 8,101 women. Women above the age of 30 years, self-referring for cervical cancer screening, were enrolled in two study centers in Hannover (Northern Germany) and Tubingen (Southern Germany). Participants were screened by the Pap smear and the hybrid capture 2 (HC2) test using the high-risk probe. All samples that were positive by the HC2 test were genotyped using the prototype PGMY09/11 PCR line blot assay. Most women in the study population h…

Adultmedicine.medical_specialtyCytodiagnosisUterine Cervical NeoplasmsCervical intraepithelial neoplasiaCohort StudiesSpecies SpecificityRisk FactorsVirologyGermanyEpidemiologymedicinePrevalenceHumansPapillomaviridaePapillomaviridaeGynecologyCervical cancerbiologybusiness.industryObstetricsMortality rateIncidence (epidemiology)Papillomavirus InfectionsMiddle Agedbiology.organism_classificationmedicine.diseaseVirologyVaccinationInfectious DiseasesPopulation studyFemalebusinessCarcinoma in SituJournal of medical virology
researchProduct

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

2014

The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine (AZA)/6-mercaptopurine (6-MP) and methotrexate (MTX), together with the advent of biological therapy. Immunomodulators are being used more often and earlier in the course of the disease.1 The introduction of biologic agents, especially inhibitors of the key proinflammatory cytokine, tumor necrosis factor alpha (TNF-α) initiated a new therapeutic era, whose use has grown continuously since their introduction in 1998.2 With such immunomodulation, the potential for opportunistic infection is a key safety concern for patients with IBD. Opp…

Adultmedicine.medical_specialtyEvidence-based practiceAdolescentOpportunistic infectionSettore MED/12 - GASTROENTEROLOGIAMEDLINEAzathioprineHIV InfectionsSettore MED/17 - MALATTIE INFETTIVEInflammatory bowel diseaseInflammatory bowel diseaseImmunocompromised HostYoung AdultRisk FactorsInfluenza HumanmedicineParasitic DiseasesHumansOpportunistic infectionsIntensive care medicineECCO guidelinesIrritable bowel syndromebusiness.industryPapillomavirus InfectionsGastroenterologyAge FactorsGeneral MedicineHerpesviridae InfectionsMiddle Agedmedicine.diseaseHepatitis BInflammatory Bowel DiseasesHepatitis CVaccinationMycosesInfectious disease (medical specialty)ImmunologyHuman medicinebusinessmedicine.drug
researchProduct

Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors.

2005

Few data exist on attendance for cervical and breast cancer screening, breast self-examination and knowledge about risk factors for cervical cancer among German women. A population-based survey was performed in the city of Bielefeld in Germany.A questionnaire was mailed to 1500 randomly selected women age 25 to 75. Of those, 540 questionnaires were returned and 532 were analysed.Women participating in the survey considered themselves well informed about possibilities for early detection of breast cancer (84.0%). Most information was received from office-based gynaecologists (82.4%). 82.8% had a breast examination by a medical doctor annually and 43.1% practised breast self-examination every…

Adultmedicine.medical_specialtyHealth Knowledge Attitudes PracticePopulationUterine Cervical NeoplasmsBreast NeoplasmsBreast cancer screeningBreast cancerPatient Education as TopicRisk FactorsGermanySurveys and QuestionnairesCancer screeningMedicineMammographyHumansRisk factoreducationPapillomaviridaePhysical ExaminationAgedGynecologyCervical cancerVaginal Smearseducation.field_of_studyMotivationmedicine.diagnostic_testbusiness.industryObstetricsPublic Health Environmental and Occupational HealthBreast Self-ExaminationMiddle AgedPatient Acceptance of Health Caremedicine.diseasePopulation studyFemalebusinessMammographyPapanicolaou TestEuropean journal of public health
researchProduct

Clinical comparison of extracorporeal piezoelectric lithotripsy (EPL) and intracorporeal electrohydraulic lithotripsy (EHL) in difficult bile duct st…

1995

Today, nearly 90% of common bile duct stones are extracted endoscopically. Problems are encountered if there are large stones or a duct stenosis. Extracorporeal piezoelectric lithotripsy (EPL) as well as intracorporeal electrohydraulic lithotripsy (EHL) serve as an alternative to surgical intervention for those few patients in whom endoscopic measures have failed. A total of 35 patients with common bile duct stones in whom conventional endoscopic treatment had failed were selected on the condition that stone visualization through ultrasound was possible and that the papilla was within easy reach of the endoscope. Patients fulfilling the inclusion criteria were randomly treated either by EPL…

Adultmedicine.medical_specialtyPhysiologymedicine.medical_treatmentGallstonesLithotripsyExtracorporealLithotripsymedicineHumansProspective StudiesTreatment FailureAgedAged 80 and overCommon bile ductBile ductbusiness.industryRemission InductionGastroenterologyMiddle AgedExtracorporeal shock wave lithotripsyLaser lithotripsySurgeryMajor duodenal papillamedicine.anatomical_structureBiliary tractbusinessDigestive diseases and sciences
researchProduct

Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy.

2009

We determined the prevalence of human papillomavirus (HPV) cervical infection and HPV genotypes among 115 women immigrating to Sicily (Italy), with regard to abnormal cytology and socio-behavioral characteristics in a cross-sectional, observational study. Information was collected with the help of cultural mediators/translators. HPV-DNA was assayed by the INNOLiPA HPV assay and a nested PCR/sequencing method. Sixty (52.2%) women came from sub-Saharan Africa and 55 (47.8%) from Eastern Europe. HPV infection was found in 55 (47.8%) women. The most frequent types were the oncogenic types HPV-16 (7.8%), HPV-18 and 51 (6.0% each), HPV-52 (5.2%), 31, 53, and 68 (4.3% each). Twenty-seven (23.5%) w…

Adultmedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypePrevalenceCervicitisEmigrants and ImmigrantsUterine Cervical NeoplasmsCervix UteriSettore MED/01 - Statistica MedicaUterine Cervical DiseasesYoung AdultEpidemiologyGenotypemedicinePrevalenceHumansEurope EasternCervixPapillomaviridaeCervical cancerGynecologybusiness.industryObstetricsPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and GynecologyGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsmedicine.anatomical_structureCervical HPV infection HPV genotype distribution immigrant womenCross-Sectional StudiesItalyAfricaFemalebusinessNested polymerase chain reactionActa obstetricia et gynecologica Scandinavica
researchProduct

A pigmented papule acting like a playful ghost: dermoscopy of three targetoid hemosiderotic hemangiomas

2018

Targetoid hemosiderotic hemangioma represents an uncommon, distinctive, benign lympho-vascular lesion, with a variable clinical appearance, typically occurs in the lower limbs and trunk. Most patients are in their 20's or 30's. We describe three dermoscopic cases followed by the review of the literature. Dermoscopic images have been collected and have been evaluated for the presence of dermoscopic features. Concerning the review, we researched on pubmed and records were reviewed noting patient age of onset, sex, location, overall size, dermoscopic appearance. The harmonic mean age of patients was 31 years; the female-to-male ratio was 1:1, and the most common locations were lower extremitie…

Adultmedicine.medical_specialtySkin NeoplasmsTargetoid hemosiderotic hemangiomaDermoscopyDermatologyLesionDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineDermismedicineHumanshemosiderotic hemangiomasbusiness.industryPapillary dermisEndothelial CellsPapuleClinical appearancemedicine.diseaseTrunkDermatologymedicine.anatomical_structureHomogeneous030220 oncology & carcinogenesisFemalemedicine.symptombusinessHemangioma
researchProduct